MedTrace Logo

In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors

NCT01236300 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2016-06-08

Study results available
· View outcomes & findings →

Summary

Assess the safety and efficacy of the Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system in differentiating benign from malignant and premalignant cysts (e.g. mucinous from non-mucinous cysts)

Conditions

  • Pancreatic Cysts

Interventions

DEVICE

Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system

Sponsors & Collaborators

  • Mauna Kea Technologies

    collaborator INDUSTRY

  • Institut Paoli-Calmettes

    collaborator OTHER

  • Technical University of Munich

    collaborator OTHER

  • Yale University

    collaborator OTHER

  • University of California, Irvine

    collaborator OTHER

  • Mayo Clinic

    collaborator OTHER

  • University of Washington

    collaborator OTHER

  • Cedars-Sinai Medical Center

    collaborator OTHER

  • University of Chicago

    lead OTHER

Principal Investigators

  • Irving Waxman, MD · University of Chicago

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-08-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01236300 on ClinicalTrials.gov